Japanese Melanoma Study Group, Tsukuba, Japan.
Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society, Kumamoto, Japan.
Cancer Med. 2019 May;8(5):2146-2156. doi: 10.1002/cam4.2110. Epub 2019 Apr 1.
The incidence of melanoma among those of an Asian ethnicity is lower than in Caucasians; few large-scale Asian studies that include follow-up data have been reported.
To investigate the clinical characteristics of Japanese patients with melanoma and to evaluate the prognostic factors.
Detailed patient information was collected from the database of Japanese Melanoma Study Group of the Japanese Skin Cancer Society. The American Joint Committee on Cancer seventh Edition system was used for TNM classification. The Kaplan-Meier method and Cox proportional hazards model were used to estimate the impact of clinical and histological parameters on disease-specific survival in patients with invasive melanoma.
In total, 4594 patients were included in this analysis. The most common clinical type was acral lentiginous melanoma (40.4%) followed by superficial spreading melanoma (20.5%), nodular melanoma (10.0%), mucosal melanoma (9.5%), and lentigo maligna melanoma (8.1%). The 5-year disease-specific survival for each stage was as follows: IA = 98.0%, IB = 93.9%, IIA = 94.8%, IIB = 82.4%, IIC = 71.8%, IIIA = 75.0%, IIIB = 61.3%, IIIC = 41.7%, and IV = 17.7%. Although multivariate analysis showed that clinical classifications were not associated with survival across all stages, acral type was an independent poor prognostic factor in stage IIIA.
Our study revealed the characteristics of melanoma in the Japanese population. The 5-year disease-specific survival of each stage showed a similar trend to that of Caucasians. While clinical classification was not associated with survival in any stages, acral type was associated with poor survival in stage IIIA. Our result might indicate the aggressiveness of acral type in certain populations.
亚洲人种的黑色素瘤发病率低于白种人;鲜有包括随访数据的大型亚洲研究报告。
调查日本黑色素瘤患者的临床特征,并评估预后因素。
从日本皮肤癌学会日本黑色素瘤研究组的数据库中收集详细的患者信息。采用美国癌症联合委员会第七版系统进行 TNM 分期。采用 Kaplan-Meier 法和 Cox 比例风险模型评估临床和组织学参数对侵袭性黑色素瘤患者疾病特异性生存的影响。
本分析共纳入 4594 例患者。最常见的临床类型是肢端雀斑样黑色素瘤(40.4%),其次是浅表扩散型黑色素瘤(20.5%)、结节型黑色素瘤(10.0%)、黏膜黑色素瘤(9.5%)和恶性雀斑样黑色素瘤(8.1%)。各期的 5 年疾病特异性生存率如下:IA=98.0%,IB=93.9%,IIA=94.8%,IIB=82.4%,IIC=71.8%,IIIA=75.0%,IIIB=61.3%,IIIC=41.7%,IV 期=17.7%。尽管多因素分析显示临床分类与各期生存率无关,但肢端型在 IIIA 期是独立的不良预后因素。
本研究揭示了日本人群黑色素瘤的特征。各期的 5 年疾病特异性生存率呈现出与白种人相似的趋势。虽然临床分类与任何分期的生存率均无关,但肢端型与 IIIA 期的不良预后相关。我们的结果可能表明肢端型在某些人群中具有侵袭性。